PARP1 and neoplasm: Mechanistically, FOXD3-AS1 interacts with poly (ADP-ribose) polymerase 1 (PARP1) to repress the poly(ADP-ribosyl)ation and activation of CCCTC-binding factor (CTCF), leading to de-repression of downstream tumour-suppressive genes [119].